Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Chugai discloses erythromycins for gastrointestinal disorders

Nov. 27, 1996

Japanese researchers describe orally active antihypertensive agents

Nov. 27, 1996

New NO inhibitors disclosed by Fujisawa

Nov. 27, 1996

New taxane derivatives from Rhone-Poulenc Rorer

Nov. 27, 1996

New antioxidant from Shiseido shows CNS activity

Nov. 27, 1996

New cardiovascular agents claimed by Hoechst

Nov. 27, 1996

Takeda discloses new agents for neurodegenerative disorders

Nov. 27, 1996

Lilly claims 5-HT7 antagonist for GI indications

Nov. 26, 1996

HMG-CoA reductase inhibitors for preventing second heart attack

Nov. 26, 1996

Neuregulin polypeptides described for treating retinal disorders

Nov. 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...